Scientists have deciphered how an activated catalyst breaks down the strong carbon-hydrogen bonds in potent greenhouse gas methane, according to a study published in Science. Using advanced X-ray technology and quantum-chemical calculations, they tracked the electron exchange between the catalyst and the methane molecule, paving the way for developing more efficient catalysts to convert harmful gases into useful chemicals.
The use of short flashes of X-ray light brings scientists one big step closer to developing better catalysts to transform the greenhouse gas methane into a less harmful chemical. The result, published in the journal Science, reveals for the first time how carbon-hydrogen bonds of alkanes break and how the catalyst works in this reaction.
Methane, one of the most potent greenhouse gases, is being released into the atmosphere at an increasing rate by livestock farming as well as the continuing unfreezing of permafrost. Transforming methane and longer-chain alkanes into less harmful and in fact useful chemicals would remove the associated threats, and in turn make a huge feedstock for the chemical industry available. However, transforming methane necessitates as a first step the breaking of a C-H bond, one of the strongest chemical linkages in nature.
The research was led by scientists from Uppsala University in collaboration with the Paul Scherrer Institute in Switzerland, Stockholm University, Hamburg University and the European XFEL in Germany. For the first time, the scientists were able to directly watch the catalyst at work and reveal how it breaks those C-H bonds.
Raphael Jay, Researcher at the Department of Physics and Astronomy, Uppsala University. Credit: Mikael Wallerstedt
In two experiments conducted at the Paul Scherrer Institute in Switzerland, the researchers were able to follow the delicate exchange of electrons between a rhodium catalyst and an octane C-H group as it gets broken. Using two of the most powerful sources of X-ray flashes in the world, the X-ray laser SwissFEL and the X-ray synchrotron Swiss Light Source, the reaction could be followed all the way from the beginning to the end. The measurements revealed the initial light-induced activation of the catalyst within 400 femtoseconds (0.0000000000004 seconds) to the final C-H bond breaking after 14 nanoseconds (0.000000014 seconds).
“The time-resolved X-ray absorption experiments we performed are only possible at large-scale facilities like SwissFEL and the Swiss Light Source, which provide extremely bright and short X-ray pulses. The catalyst is immersed in a dense octane solution, but by taking the perspective of the metal, we could specifically pick the one C-H bond out of hundreds of thousands which is made to break,” explains Raphael Jay, Researcher at Uppsala University and lead experimentalist of the study.
Philippe Wernet, Professor at the Department of Physics and Astronomy, Uppsala University. Credit: Mikael Wallerstedt
To interpret the complex experimental data, theoreticians from Uppsala University and Stockholm University teamed up and performed advanced quantum-chemical calculations.
“Our calculations allow us to clearly identify how electronic charge flows between the metal catalyst and the C-H group in just the right proportion. We can see how charge flowing from the metal onto the C-H bond glues the two chemical groups together. Charge flowing in the opposite direction instead acts as a scissor that eventually breaks the C and the H atom apart,” explains Ambar Banerjee, Postdoctoral researcher at Uppsala University and lead theoretician of the study.
The study solves a forty-year-old mystery about how an activated catalyst can actually break strong C-H bonds by carefully exchanging fractions of electrons and without the need for huge temperatures or pressures. With their new tool to hand, the researchers next want to learn how to direct the flow of electrons to help develop better catalysts for the chemical industry in order to make something useful out of methane and other alkanes.
Facts
The study builds on the pioneering work of grandfather, father and son Manne, Kai, and Per Siegbahn.
Manne Siegbahn (Uppsala University), who received the Nobel Prize in Physics in 1924, pioneered how different elements can be distinguished by X-rays.
Kai Siegbahn (Uppsala University), who received the Nobel Prize in Physics in 1981, pioneered how different chemical environments of the same element can be distinguished by X-rays.
Per Siegbahn (Stockholm University) theoretically predicted the concerted exchange of electronic charge required for breaking a C-H bond.
Reference: “Tracking C-H activation with orbital resolution” by Raphael M. Jay, Ambar Banerjee, Torsten Leitner, Ru-Pan Wang, Jessica Harich, Robert Stefanuik, Hampus Wikmark, Michael R. Coates, Emma V. Beale, Victoria Kabanova, Abdullah Kahraman, Anna Wach, Dmitry Ozerov, Christopher Arrell, Philip J. M. Johnson, Camelia N. Borca, Claudio Cirelli, Camila Bacellar, Christopher Milne, Nils Huse, Grigory Smolentsev, Thomas Huthwelker, Michael Odelius and Philippe Wernet, 1 June 2023, Science.
DOI: 10.1126/science.adf8042

News
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]
Aging Spreads Through the Bloodstream
Summary: New research reveals that aging isn’t just a local cellular process—it can spread throughout the body via the bloodstream. A redox-sensitive protein called ReHMGB1, secreted by senescent cells, was found to trigger aging features [...]
AI and nanomedicine find rare biomarkers for prostrate cancer and atherosclerosis
Imagine a stadium packed with 75,000 fans, all wearing green and white jerseys—except one person in a solid green shirt. Finding that person would be tough. That's how hard it is for scientists to [...]